Article Sidebar
Published:
Jul 25, 2019
Keywords:
Chemoradiation, gemcitabine, low dose, pancreatic cancer, unresectable
How to Cite
Beste Melek ATASOY, Faysal DANE, Ayşegül ÜÇÜNCÜ KEFELİ, Hale ÇAĞLAR, Asım CİNGİ, Nazım Serdar TURHAL, … Cumhur YEĞEN. (2019). Concomitant chemoradiotherapy with low-dose weekly gemcitabine for nonmetastatic unresectable pancreatic cancer. Turkish Journal of Gastroenterology, 22(1), 60–64. Retrieved from https://tjg.avesjournals.com/index.php/tjg/article/view/2407
Main Article Content
Beste Melek ATASOY
Departments of Radiation Oncology
Faysal DANE
Departments of Internal Medicine Division of Medical Oncology
Ayşegül ÜÇÜNCÜ KEFELİ
Departments of Radiation Oncology
Hale ÇAĞLAR
Departments of Radiation Oncology
Asım CİNGİ
Departments of General Surgery, Marmara University School of Medicine, İstanbul
Nazım Serdar TURHAL
Departments of Internal Medicine Division of Medical Oncology
Ufuk ABACIOĞLU
Departments of Radiation Oncology
Cumhur YEĞEN
Departments of General Surgery, Marmara University School of Medicine, İstanbul
Concomitant chemoradiotherapy with low-dose weekly gemcitabine for nonmetastatic unresectable pancreatic cancer
Main Article Content
Beste Melek ATASOY
Departments of Radiation Oncology
Faysal DANE
Departments of Internal Medicine Division of Medical Oncology
Ayşegül ÜÇÜNCÜ KEFELİ
Departments of Radiation Oncology
Hale ÇAĞLAR
Departments of Radiation Oncology
Asım CİNGİ
Departments of General Surgery, Marmara University School of Medicine, İstanbul
Nazım Serdar TURHAL
Departments of Internal Medicine Division of Medical Oncology
Ufuk ABACIOĞLU
Departments of Radiation Oncology
Cumhur YEĞEN
Departments of General Surgery, Marmara University School of Medicine, İstanbul
Abstract
-